➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
Harvard Business School
Boehringer Ingelheim
McKesson

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Bacitracin - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for bacitracin and what is the scope of freedom to operate?

Bacitracin is the generic ingredient in twenty-one branded drugs marketed by X Gen Pharms, Akorn, Fresenius Kabi Usa, Mylan Asi, Pfizer, Pharmacia And Upjohn, Xellia Pharms Aps, Lilly, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Combe, Naska, Apothekernes, Paddock Llc, Casper Pharma Llc, Bausch And Lomb, Monarch Pharms, Dow Pharm, Glaxosmithkline, and Altana, and is included in forty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for bacitracin. Seven suppliers are listed for this compound.

Drug Prices for bacitracin

See drug prices for bacitracin

Recent Clinical Trials for bacitracin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityEarly Phase 1
Ascension South East MichiganPhase 4
The University of Texas Health Science Center, HoustonPhase 4

See all bacitracin clinical trials

Pharmacology for bacitracin
Medical Subject Heading (MeSH) Categories for bacitracin

US Patents and Regulatory Information for bacitracin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Combe BACITRACIN bacitracin OINTMENT;TOPICAL 062799-001 May 14, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Asi BACITRACIN bacitracin INJECTABLE;INJECTION 090211-001 May 11, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn BACITRACIN bacitracin INJECTABLE;INJECTION 060733-002 Approved Prior to Jan 1, 1982 AP RX No Yes   Start Trial   Start Trial   Start Trial
Naska BACITRACIN bacitracin OINTMENT;TOPICAL 062857-001 Nov 13, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo Co Tennessee NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060764-002 Approved Prior to Jan 1, 1982 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
Harvard Business School
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.